Preoperative pulmonary hypertension and its impact on survival after heart transplantation

Scandinavian Cardiovascular Journal

Volumn 48, Issue 1, 2014, Pages 47-58

  Lundgren, Jakob ^a,b   Algotsson, Lars ^a   Kornhall, Björn ^a   Rådegran, Göran ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Haemodynamic; Heart failure; Heart transplantation; Pulmonary hypertension; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SURVIVAL; SWAN GANZ CATHETER; VASODILATATION; VASOPLEGIA; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893235368     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2013.877153     Document Type: Article

References (30)

1. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al . Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) . Eur Heart J. 2009; 30 : 2493 - 537 .
2. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry . Ann Intern Med. 1991; 115 : 343 - 9 .
3. Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis G D, Rame JE, et al . World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult - a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation . J Heart Lung Transplant. 2012; 31 : 913 - 33 .
4. Mehra M R, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al . Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006 . J Heart Lung Transplant. 2006; 25 : 1024 - 42 .
5. Costard-Jackle A, Fowler MB . Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group . J Am Coll Cardiol. 1992; 19 : 48 - 54 .
6. Murali S, Kormos R L, Uretsky B F, Schechter D, Reddy PS, Denys BG, et al . Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience . Am Heart J. 1993; 126 : 896 - 904 .
7. Lindelow B, Andersson B, Waagstein F, Bergh CH. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate . Eur Heart J . 1999; 20 : 148 - 56 .
8. Delgado J F, Gomez-Sanchez M A, Saenzdl C, Sanchez V, Escribano P, Hernandez-Afonso J, et al . Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation . J Heart Lung Transplant. 2001; 20 : 942 - 8 .
9. Klotz S, Deng MC, Hanafy D, Schmid C, Stypmann J, Schmidt C, et al . Reversible pulmonary hypertension in heart transplant candidates - pretransplant evaluation and outcome after orthotopic heart transplantation . Eur J Heart Fail. 2003; 5 : 645 - 53 .
10. Chang PP, Longenecker JC, Wang NY, Baughman K L, Conte JV, Hare JM, Kasper EK . Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality . J Heart Lung Transplant. 2005; 24 : 998 - 1007 .
11. Goland S, Czer L S, Kass R M, De Robertis M A, Mirocha J, Coleman B, et al . Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation . J Heart Lung Transplant. 2007; 26 : 312 - 8 .
12. Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C, Scheld HH . Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant . Ann Thorac Surg. 2006; 82 : 1770 - 3 .
13. Gude E, Simonsen S, Geiran OR, Fiane AE, Gullestad L, Arora S, et al . Pulmonary hypertension in heart transplantation: discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics . J Heart Lung Transplant. 2010; 29 : 216 - 23 .
14. Butler J, Stankewicz MA, Wu J, Chomsky DB, Howser RL, Khadim G, et al . Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation . J Heart Lung Transplant. 2005; 24 : 170 - 7 .
15. Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L . Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur J Cardiothorac Surg. 2009; 35 : 1029 - 34 .
16. Kettner J, Dorazilova Z, Netuka I, Maly J, Al-Hiti H, Melenovsky V, et al . Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol Res. 2011; 60 : 769 - 75 .
17. Naeije R, Vachiery J, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease . Eur Respir J. 2012 .
18. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, et al . Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in " out-of-proportion " pulmonary hypertension . Chest. 2013; 143 : 758 - 66 .
19. John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M . Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices . J Thorac Cardiovasc Surg. 2010; 140 : 447 - 52 .
20. Nair P K, Kormos R L, Teuteberg J J, Mathier M A, Bermudez CA, Toyoda Y, et al . Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension . J Heart Lung Transplant. 2010; 29 : 201 - 8 .
21. John R, Kamdar F, Eckman P, Colvin-Adams M, Boyle A, Shumway S, et al . Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices . Ann Thorac Surg. 2011; 92 : 1593 - 9 .
22. Kato T S, Stevens GR, Jiang J, Christian SP, Gukasyan N, Lippel M, et al . Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation . J Heart Lung Transplant. 2013; 32 : 333 - 40 .
23. Kato TS, Chokshi A, Singh P, Khawaja T, Iwata S, Homma S, et al . Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure . J Heart Lung Transplant. 2012; 31 : 37 - 45 .
24. Mogollon MV, Lage E, Cabezon S, Hinojosa R, Ballesteros S, Aranda A, et al . Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report . Transplant Proc. 2006; 38 : 2522 - 3 .
25. Haddad F, Kudelko K, Mercier O, Vrtovec B, Zamanian RT, de Jesus Perez V . Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies . Prog Cardiovasc Dis. 2011; 54 : 154 - 67 .
26. De Santo LS, Romano G, Maiello C, Buonocore M, Cefarelli M, Galdieri N, et al . Pulmonary artery hypertension in heart transplant recipients: how much is too much? Eur J Cardiothorac Surg. 2012; 42 : 864 - 9 .
27. Pons J, Leblanc MH, Bernier M, Cantin B, Bourgault C, Bergeron S, et al . Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation . J Heart Lung Transplant. 2012; 31 : 1281 - 7 .
28. Califf R M, Adams K F, McKenna W J, Gheorghiade M, Uretsky BF, McNulty SE, et al . A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) . Am Heart J. 1997; 134 : 44 - 54 .
29. Kalra PR, Moon JC, Coats AJ . Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol. 2002; 85 : 195 - 7 .
30. Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, et al . Long-term effects of darusentan on leftventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial . Lancet. 2004; 364 : 347 - 54 .